Addex Therapeutics Ltd
ADXN | NASDAQ
$3.53
+$0.13 (+3.98%)
At close: Sep 21, 2026, 4:00 PM ET
$3.32
-$0.21 (-5.95%)
Pre-market:
Sep 22, 2026, 4:31 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.89 | 0.76 | -0.30 | -0.21 | -2.12 | -4.12 |
PEG Ratio | 0 | -0.01 | 0 | -0.09 | 0.34 | 0.29 |
PS Ratio | 191.02 | 12.86 | 1.95 | 3.08 | 11.18 | 14.61 |
PB Ratio | 1.20 | 0.54 | 2.75 | 0.89 | 1.93 | 3.61 |
P/FCF Ratio | -2.76 | -0.97 | -0.39 | -0.27 | -2.21 | -4.31 |
P/OCF Ratio | -2.76 | -0.97 | -0.39 | -0.27 | -2.22 | -4.33 |
OCF/S Ratio | -6.93K | -1.33K | -495.51 | -1.16K | -504.24 | -337.13 |
Debt / Equity Ratio | 0.01 | 0 | 0.30 | 0.08 | 0.03 | 0.04 |
Quick Ratio | 1.40 | 4.42 | 1.46 | 2.39 | 5.31 | 5.34 |
Current Ratio | 1.40 | 4.42 | 1.46 | 2.39 | 5.31 | 5.38 |
Asset Turnover | 0 | 0.04 | 0.35 | 0.17 | 0.13 | 0.18 |
Interest Coverage | -1.16K | -776.78 | -103.81 | -215.57 | -246.08 | -176.16 |
Return on Equity | -141.14% | 72.91% | -921.57% | -423.46% | -90.67% | -88.01% |
Return on Assets | -105.68% | 66.08% | -227.41% | -251.20% | -68.10% | -63.71% |
Return on Invested Capital | -54.40% | -27.88% | -110.90% | -199.41% | -82.94% | -72.58% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 100% | 100% | 100% |
Net Profit Margin | -22.45K% | 1.75K% | -654.47% | -1.46K% | -526.42% | -355.92% |
Pretax Profit Margin | -22.83K% | -1.21K% | -155% | -759.54% | -526.42% | -355.92% |
Operating Profit Margin | -9.39K% | -681.82% | -139.06% | -741.04% | -531.70% | -338.88% |
FCF Margin | -6.93K% | -1.33K% | -495.94% | -1.16K% | -505.32% | -338.78% |
EBITDA Margin | -22.79K% | -1.15K% | -135.80% | -734.86% | -512.34% | -343.51% |
Add to Watchlist
Select watchlists to add or remove ADXN